Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Dharmarajan

Arunasalam Dharmarajan, Willetton AU

Patent application numberDescriptionPublished
20090170771Anti-angiogenic agents and methods of their use - The present invention relates to the use of sFRP-4 and functional variants thereof as anti-angiogenic agents. It relates to methods of treatment and screening methods using sFRP-4 and functional variants thereof. Further, it relates to compositions, and in particular pharmaceutical composition, including sFRP-4 and functional variants thereof which may be used in the various methods provided herein.07-02-2009

Manjeri Ramanathan Dharmarajan, Bangalore IN

Patent application numberDescriptionPublished
20090049306Method, Computer System, and Computer Program Product for Password Generation - The generation of a unique password using a secret key and an application name is disclosed. Other passwords may be generated for other applications using the same key. A user provides a key that is not easily able to be guessed by third parties. The user also inputs a name of an application for which a password is desired. The system utilises the application name and the secret key to generate a unique password for that application, using standard encryption techniques. The system generates the same password for that application and secret key combination every time. Alternate embodiments generate a user identifier from the same secret key and application name.02-19-2009
20090119761Apparatus and computer program product for password generation - The generation of a unique password using a secret key and an application name is disclosed. Other passwords may be generated for other applications using the same key. A user provides a key that is not easily able to be guessed by third parties. The user also inputs a name of an application for which a password is desired. The system utilises the application name and the secret key to generate a unique password for that application, using standard encryption techniques. The system generates the same password for that application and secret key combination every time. Alternate embodiments generate a user identifier from the same secret key and application name.05-07-2009

Sankaranarayanan Dharmarajan, Gurgaon IN

Patent application numberDescriptionPublished
20080300196MONOSACCHARIDE DERIVATIVES - The present invention relates to monosaccharide derivatives as anti-inflammatory agents. The compounds disclosed herein can be useful for inhibition and prevention of inflammation and associated pathologies including inflammatory, cancer, cardiovascular and autoimmune diseases such as bronchial asthma, rheumatoid arthritis, type-I diabetes, multiple sclerosis, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, pruritis or allergic rhinitis. Pharmacological compositions containing compounds disclosed herein and the methods of treating diseases such as bronchial asthma, rheumatoid arthritis, type-I diabetes, multiple sclerosis, cancer, cardiovascular diseases, allograft rejection, psoriasis, inflammatory bowel disease, ulcerative colitis, acne, atherosclerosis, pruritis or allergic rhinitis and other inflammatory and/or autoimmune disorders, using the compounds are also provided.12-04-2008
200803190433,6-Disubstituted Azabicyclo (3.1.0) Hexane Derivatives as Muscarinic Receptor Antagonists - The present invention generally relates to muscarinic receptor antagonists, which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.12-25-2008

Sankaranarayanan Dharmarajan, Haryana IN

Patent application numberDescriptionPublished
20080280883Muscarinic Receptor Antagonists - This present invention generally relates to muscarinic receptor antagonists which are useful, among other uses, for the treatment of various diseases of the respiratory, urinary and gastrointestinal systems mediated through muscarinic receptors. The invention also relates to the process for the preparation of disclosed compounds, pharmaceutical compositions containing the disclosed compounds, and the methods for treating diseases mediated through muscarinic receptors.11-13-2008